US Bancorp
HRMY icon

US Bancorp’s Harmony Biosciences HRMY Stock Holding History

US Bancorp’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8K Buy
406
+101
+33% +$3.19K ﹤0.01% 3326
2026
Q1 		$8.54K Sell
305
-115
-27% -$3.77K ﹤0.01% 3411
2025
Q4 		$15.7K Sell
420
-170
-29% -$5.59K ﹤0.01% 3171
2025
Q3 		$16.3K Sell
590
-19
-3% -$655 ﹤0.01% 3141
2025
Q2 		$19.2K Buy
609
+34
+6% +$1.09K ﹤0.01% 3181
2025
Q1 		$19.1K Hold
575
– – ﹤0.01% 3194
2024
Q4 		$19.8K Hold
575
– – ﹤0.01% 3164
2024
Q3 		$23K Sell
575
-9,524
-94% -$335K ﹤0.01% 3071
2024
Q2 		$305K Buy
10,099
+2,040
+25% +$61.3K ﹤0.01% 1778
2024
Q1 		$271K Sell
8,059
-581
-7% -$18.6K ﹤0.01% 1854
2023
Q4 		$279K Buy
8,640
+7,673
+793% +$214K ﹤0.01% 1839
2023
Q3 		$31.7K Sell
967
-1,759
-65% -$61.1K ﹤0.01% 2659
2023
Q2 		$95.9K Buy
2,726
+465
+21% +$16.1K ﹤0.01% 2218
2023
Q1 		$73.8K Buy
2,261
+452
+25% +$20.6K ﹤0.01% 2336
2022
Q4 		$99.7K Buy
1,809
+1,150
+175% +$63.2K ﹤0.01% 2191
2022
Q3 		$29K Buy
659
+635
+2,646% +$31K ﹤0.01% 2836
2022
Q2 		$1K Sell
24
-95
-80% -$4.28K ﹤0.01% 3959
2022
Q1 		$6K Buy
+119
New +$4.85K ﹤0.01% 3546
2021
Q3 		– Sell
-17
Closed – – 4115
2021
Q2 		$0 Buy
+17
New +$510 ﹤0.01% 4031

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

US Bancorp's HRMY Position: Q2 2026 in Review

US Bancorp increased its Harmony Biosciences (HRMY) stake by 33% in Q2 2026, buying an estimated $3.19K and bringing the position to 406 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3326.

US Bancorp first reported a position in HRMY in Q2 2021 and has held it in 19 quarters since. The position peaked at $305K in Q2 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • US Bancorp held 406 shares of Harmony Biosciences worth $14.8K as of Q2 2026.
  • US Bancorp bought 101 Harmony Biosciences shares in Q2 2026, an estimated $3.19K.
  • Harmony Biosciences made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3326 holding.
  • US Bancorp first reported a position in Harmony Biosciences in Q2 2021 and has held it in 19 quarters since.
  • US Bancorp's Harmony Biosciences position peaked at $305K in Q2 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.